Literature DB >> 21549794

MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8(+) T lymphocytes.

Erica A Mendes1, Bráulia C Caetano, Marcus L O Penido, Oscar Bruna-Romero, Ricardo T Gazzinelli.   

Abstract

Toxoplasma gondii is an intracellular parasite widely spread around the world. The surface antigens (SAG) 1, 2 and 3 are the main proteins expressed on the surface of T. gondii tachyzoites. Replication-defective adenovirus serotype 5 (rAd5) is one of the most potent recombinant viral vectors for eliciting T cell-mediated immunity in mice and humans. Here we show that vaccination with rAd5 expressing SAG1 (AdSAG1), but neither SAG2 nor SAG3, induces protective immunity in the highly susceptible C57BL/6 mice challenged with T. gondii. Furthermore, we evaluated different immunological components involved on viral induced protective immunity. We observed that host protection elicited by AdSAG1 is highly dependent on IL-12, IFN-γ and CD8(+) T lymphocytes. Importantly, the induction of protective immunity (T cell-derived IFN-γ) was also dependent on Myeloid Differentiation Factor 88 (MyD88), and thus, likely to involve Toll-like Receptors. We conclude that protective parasite specific-CD8(+) T cells are elicited by a mechanism that involves MyD88-dependent induction of IL-12.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549794      PMCID: PMC3115523          DOI: 10.1016/j.vaccine.2011.04.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  67 in total

1.  Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy.

Authors:  Mathias Krummen; Sandra Balkow; Limei Shen; Stefanie Heinz; Carmen Loquai; Hans-Christian Probst; Stephan Grabbe
Journal:  J Leukoc Biol       Date:  2010-04-01       Impact factor: 4.962

2.  CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.

Authors:  Ross W B Lindsay; Patricia A Darrah; Kylie M Quinn; Ulrike Wille-Reece; Lisa M Mattei; Akiko Iwasaki; Sudhir P Kasturi; Bali Pulendran; Jason G D Gall; A Gregory Spies; Robert A Seder
Journal:  J Immunol       Date:  2010-07-07       Impact factor: 5.422

3.  Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.

Authors:  Y Suzuki; J S Remington
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

4.  Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice.

Authors:  R McLeod; E Skamene; C R Brown; P B Eisenhauer; D G Mack
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

5.  Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.

Authors:  Valentina Martin; Alicia Supanitsky; Pablo C Echeverria; Silvana Litwin; Tamara Tanos; Adolfo R De Roodt; Eduardo A Guarnera; Sergio O Angel
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

6.  Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii.

Authors:  Rajarshi Bhadra; Hongbing Guan; Imtiaz A Khan
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

7.  A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo.

Authors:  Erin E Thacker; Masaharu Nakayama; Bruce F Smith; R Curtis Bird; Zhanat Muminova; Theresa V Strong; Laura Timares; Nikolay Korokhov; Ann Marie O'Neill; Tanja D de Gruijl; Joel N Glasgow; Kenzaburo Tani; David T Curiel
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

8.  Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination.

Authors:  R Guiton; R Zagani; I Dimier-Poisson
Journal:  Parasite Immunol       Date:  2009-10       Impact factor: 2.280

9.  Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.

Authors:  Ariane Rodríguez; Ratna Mintardjo; Dennis Tax; Gert Gillissen; Jerome Custers; Maria Grazia Pau; Jaco Klap; Sampa Santra; Harikrishnan Balachandran; Norman L Letvin; Jaap Goudsmit; Katarina Radosević
Journal:  Vaccine       Date:  2009-08-15       Impact factor: 3.641

10.  Antigenic differences between endozoites and cystozoites of Toxoplasma gondii.

Authors:  M N Lunde; L Jacobs
Journal:  J Parasitol       Date:  1983-10       Impact factor: 1.276

View more
  6 in total

1.  The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden.

Authors:  Harshita Satija Grover; Nicolas Blanchard; Federico Gonzalez; Shiao Chan; Ellen A Robey; Nilabh Shastri
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

2.  A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.

Authors:  Huiquan Yin; Lingxiao Zhao; Ting Wang; Huaiyu Zhou; Shenyi He; Hua Cong
Journal:  Parasit Vectors       Date:  2015-09-30       Impact factor: 3.876

3.  Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.

Authors:  Zineb Lakhrif; Alexis Moreau; Bruno Hérault; Anne Di-Tommaso; Matthieu Juste; Nathalie Moiré; Isabelle Dimier-Poisson; Marie-Noëlle Mévélec; Nicolas Aubrey
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

4.  Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes.

Authors:  Ting Wang; Huiquan Yin; Yan Li; Lingxiao Zhao; Xiahui Sun; Hua Cong
Journal:  Parasite       Date:  2017-04-03       Impact factor: 3.000

5.  Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1.

Authors:  Érica Araújo Mendes; Flavio G Fonseca; Bárbara M Casério; Janaína P Colina; Ricardo Tostes Gazzinelli; Braulia C Caetano
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

6.  SAG2A protein from Toxoplasma gondii interacts with both innate and adaptive immune compartments of infected hosts.

Authors:  Arlindo G Macêdo; Jair P Cunha; Thyago H S Cardoso; Murilo V Silva; Fernanda M Santiago; João S Silva; Carlos P Pirovani; Deise A O Silva; José R Mineo; Tiago W P Mineo
Journal:  Parasit Vectors       Date:  2013-06-05       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.